PHARMACY

Genmab cancels development of cancer drug due to industry competition

BY Alaric DeArment

WASHINGTON Danish drug maker Genmab is stopping development of a cancer drug, citing slow patient recruitment for a phase 3 study.

Genmab said the introduction of a rival to its cutaneous T-cell lymphoma drug, zanolimumab, had made it difficult to recruit patients for the study. It also cited competing clinical trials of drugs for the same condition and a relatively small market potential for zanolimumab.

The company is also licensing three of its early-stage development programs that fall outside the therapeutic areas on which it will focus and winding down early-stage studies of the colorectal and lung cancer drug HuMax-EGFr.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Walgreens ships diabetes supplies for free to Medicare Part B patients

BY Jenna Duncan

DEERFIELD, Ill. Walgreens has announced that it ship diabetes testing supplies for free to people who have their supplies covered under Medicare Part B.

The move comes at a time when budgets are tight—especially for seniors. To make getting diabetes supplies easier and more affordable, Walgreens said, patients can pick up their testing items at one of the 6,400 stores or have supplies mailed to their home at no cost.

Those seniors who are eligible can sign up by calling 1-888-PARTB-65 (1-888-727-8265) or request a call from a Walgreens representative by logging on to https://www.walgreens.com/partb. Special Walgreens phone reps will assist with filing all of the necessary Part B claim forms and will answer any other additional questions, the company said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Bruno’s, Food World stores announce closings of many in-store pharmacies

BY Jenna Duncan

TUSCALOOSA, Ala. Bruno’s over the weekend announced that 22 out 40 in-store pharmacies in Bruno’s and Food World stored throughout Alabama and Florida will be closed. The closures will affect about 60 employees, the company said.

Bruno’s will sell remaining prescriptions and pharmaceutical inventories to CVS, a spokesman told the local media. CVS may also retain some of Bruno’s pharmacy employees.

No word yet on what Bruno’s will do with the remaining space in stores.  

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES